Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial-Reference-Cited by-同舟云学术

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Published:2009-05 Issue:5 Volume:10 Page:459-466
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Stupp Roger,Hegi Monika E,Mason Warren P,van den Bent Martin J,Taphoorn Martin JB,Janzer Robert C,Ludwin Samuel K,Allgeier Anouk,Fisher Barbara,Belanger Karl,Hau Peter,Brandes Alba A,Gijtenbeek Johanna,Marosi Christine,Vecht Charles J,Mokhtari Karima,Wesseling Pieter,Villa Salvador,Eisenhauer Elizabeth,Gorlia Thierry,Weller Michael,Lacombe Denis,Cairncross J Gregory,Mirimanoff René-Olivier

Publisher

Elsevier BV

Subject

Oncology

Reference50 articles.

1. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery;Walker;N Engl J Med,1980

2. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review;Laperriere;Radiother Oncol,2002

3. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials;Stewart;Lancet,2002

4. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

5. MGMT gene silencing and benefit from temozolomide in glioblastoma;Hegi;N Engl J Med,2005

Cited by 6359 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor perfusion enhancement by focus ultrasound-induced blood-brain barrier opening to potentiate anti-PD-1 immunotherapy of glioma;Translational Oncology;2024-11

2. Unveiling the impact of SUMOylation at K298 site of heat shock factor 1 on glioblastoma malignant progression;Neoplasia;2024-11

3. TP53 mutations and survival in patients with histologically defined Glioblastoma, IDH-wildtype;Pathology - Research and Practice;2024-10

4. Re-irradiation treatment regimens for patients with recurrent glioma – Evaluation of the optimal dose and best concurrent therapy;Radiotherapy and Oncology;2024-10

5. Surgical resection of glioblastoma in the very elderly: An analysis of survival outcomes using the surveillance, epidemiology, and end results database;Clinical Neurology and Neurosurgery;2024-10